Clinical studies recruiting near Reno

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Renown Regional Medical Center · National Cancer Institute (NCI) · NCT05564390 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Advanced Research Institute-Reno · Kallyope Inc. · NCT07674654 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Renown Regional Medical Center · NRG Oncology · NCT05624996 A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Pa
Phase 4 · Skin Cancer and Dermatology Institute - Reno · Eli Lilly and Company · NCT06857942 A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Phase N/A · Cancer Care Specialists of Reno · Tempus AI · NCT07154823 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Cancer Care Specialists · Hoffmann-La Roche · NCT06793215 A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Phase N/A · Sierra Eye Associates · Astellas Pharma Global Development, Inc. · NCT06779773 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Renown Regional Medical Center · Children's Oncology Group · NCT04322318 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Renown Health Medical Oncology · Pfizer · NCT07144280 REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain
NA · Nevada Advanced Pain Specialists · Pacific Research Institute · NCT05504499 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Sierra Nevada Specialty Care · Boehringer Ingelheim · NCT06531824 Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · Renown Regional Medical Center · NRG Oncology · NCT06532279 LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Phase 3 · Tenax Investigational Site · Tenax Therapeutics, Inc. · NCT07288398 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Renown Regional Medical Center · NRG Oncology · NCT05174169 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Renown Medical Group - Oncology/Hematology /ID# 247942 · AbbVie · NCT04928846 Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi
Phase 3 · Research Site · AstraZeneca · NCT06357533 GEMINI-NSCLC: NSCLC Biomarker Study
Phase N/A · Cancer Care Specialists Reno · Tempus AI · NCT05236114 Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator
Phase N/A · Nevada Advanced Pain Specialists · Abbott Medical Devices · NCT03876054 A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atop
Phase 3 · Skin Cancer and Dermatology Institute · Organon and Co · NCT07265479 A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancre
Phase 3 · Investigative Site US084 · Incyte Corporation · NCT07522073 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Renown Regional Medical Center · Bristol-Myers Squibb · NCT06561386 eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (CO
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT07177339 ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Phase N/A · Hemostasis and Thrombosis Center of Nevada · American Thrombosis and Hemostasis Network · NCT04398628 A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H
Phase 2/Phase 3 · Northern Nevada Endocrinology /ID# 259646 · AbbVie · NCT06345339 A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed A
Phase 3 · Renown Regional Medical Center · Children's Oncology Group · NCT04293562 A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (M
Phase 3 · Renown Regional Medical Center-Renown Health Medical Oncolog · Merck Sharp & Dohme LLC · NCT07513376 A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson'
Phase 3 · Renown Health · Hoffmann-La Roche · NCT07174310 A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants Wi
Phase 3 · Research Site · AstraZeneca · NCT05211895 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Renown Regional Medical Center · Alliance for Clinical Trials in Oncology · NCT04242095

Look up another city

Look up another condition